Table 1 Baseline characteristics of participants according to metabolic health and obesity

MHNO

47(41, 54)

1836(37.26)

594(12.05)

21.85 ± 1.75

MHO

48(42, 55)

1667(65.71)^a

512(20.18) ^a

26.62 ± 1.82 ^a

MUNO

52(46, 58)^a,b

980(49.72)^a,b

344(17.45) ^a,b

22.76 ± 1.40 ^a,b

MUO

51(45, 57) ^a,b

2969(74.22)^a,bc

1071(26.77) ^a,bc

27.46 ± 2.35 ^a,bc

SBP (mmHg)

DBP (mmHg)

WBCC (109/L)

Neutrophil count(109/L)

FPG (mmol/L)

HbA1c (%)

MHNO

117(108,126)

71(65,78)

5.41 ± 1.37

3.15 ± 1.08

5.08 ± 0.56

5.41 ± 0.41

MHO

122(114, 132) ^a

76(70, 82) ^a

5.78 ± 1.48 ^a

3.33 ± 1.16 ^a

5.16 ± 0.58 ^a

5.48 ± 0.44 ^a

MUNO

132(121,141) ^a,b

80(72,87) ^a,b

5.87 ± 1.49 ^a

3.45 ± 1.15 ^a,b

5.94 ± 1.71 ^a,b

5.81 ± 0.96 ^a,b

MUO

135(126, 146) ^a,bc

85(77, 91) ^a,bc

6.19 ± 1.52 ^a,bc

3.60 ± 1.17 ^a,bc

6.08 ± 1.57 ^a,bc

5.91 ± 0.94 ^a,bc

TC (mmol/L)

TG (mmol/L)

LDL-C (mmol/L)

HDL-C (mmol/L)

Uric acid (umol/l)

MHNO

5.28 ± 1.00

1.04 (0.81, 1.34)

3.20 ± 0.74

1.51 ± 0.30

285(242,342)

MHO

5.32 ± 0.99

1.26(1.00, 1.54) ^a

3.34 ± 0.75 ^a

1.34 ± 0.24 ^a

344(287, 403) ^a

MUNO

5.46 ± 1.11 ^a,b

1.85(1.35, 2.48) ^a,b

3.42 ± 0.79 ^a,b

1.25 ± 0.28 ^a,b

319(271,378) ^a,b

MUO

5.48 ± 1.14 ^a,b

2.13(1.62, 2.96) ^a,bc

3.46 ± 0.79 ^a,b

1.16 ± 0.24 ^a,bc

371(314, 429) ^a,bc